Alan B. Lancz & Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,300	Closed	-$147K	–	175
2022 Q4	$147K	Sell	1,300 -500	-28%	-$56.4K	0.15%	168
2022 Q3	$153K	Hold	1,800	–	–	0.18%	136
2022 Q2	$155K	Buy	+1,800	New	+$155K	0.15%	155